Venkat Ramanan
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Venkat Ramanan is currently Chief Financial Officer at Immatics NV since 2025.
Former positions include Chief Financial Officer at Turnstone Biologics Corp.
from 2022 to 2024, Chief Financial Officer at Anthos Therapeutics, Inc., and Senior Vice President-Finance at Seagen, Inc. Education includes a doctorate from The Ohio State University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMMATICS N.V. -.--% | 18/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| IMMATICS N.V. | Directeur Financier/CFO | 01/10/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
| TURNSTONE BIOLOGICS CORP. | Directeur Financier/CFO | 25/10/2024 |
| SEAGEN INC. | Directeur Financier/CFO | - |
Anthos Therapeutics, Inc.
Anthos Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutic options for the treatment of cardiovascular metabolic diseases | Directeur Financier/CFO | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Seagen, Inc.
Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Turnstone Biologics Corp.
Turnstone Biologics Corp. BiotechnologyHealth Technology Develops and sells medicines to treat and cure solid tumors | Health Technology |
Anthos Therapeutics, Inc.
Anthos Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutic options for the treatment of cardiovascular metabolic diseases | Health Technology |
Immatics NV
Immatics NV Pharmaceuticals: MajorHealth Technology Engages in developing immunotherapies for cancer treatments | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national